Disease etiology
(A) Overall distribution of the types of RNAi-treated diseases in the published and ongoing clinical trials, from 2008 to 2023 and 2015 to 2023, respectively. (B) Overall distribution of the types of RNAi-treated diseases using i.v. administration in the published and ongoing clinical trials, from 2008 to 2023 and 2015 to 2023, respectively. (C) Overall distribution of the types of RNAi-treated diseases using s.c. administration in the published and ongoing clinical trials from 2008 to 2023 and 2015 to 2023, respectively. Diseases are grouped by etiology. Color-coded annotations are included for every distribution.